Prothena Corp Public PRTA
NASDAQ PRTA
$8.78 +0.06 (+0.69%)
At close: Sep 29, 2026 · 4:00 PM EDT

Prothena Corp Public (PRTA) EV to EBIT (2021 - 2022)

Updated

Prothena Corp Public's EV to EBIT was 17.64 in Q1 2022, down 26.4% from the prior quarter.

Analysis

Prothena Corp Public (PRTA) EV to EBIT (2021 - 2022) Analysis & Trends

On a trailing twelve-month basis, Prothena Corp Public's EV to EBIT was -6.23 through Mar 31, 2022; for FY2021, it came in at 23.98.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Prothena Corp Public 451.21 Mn -804.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 17.64
Dec 31, 2021 23.98
Sep 30, 2021 36.31
API Access

Prothena Corp Public EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=PRTA&period=max&api_key=YOUR_API_KEY